New

Joint Pain Injection Market

2021

Joint Pain Injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug (Hyaluronic Acid, Corticosteroid, and Others), Joint Type (Knee, Foot and Ankle, Shoulder and Elbow, Hip, and Others), and Distribution Channel (Retail Pharmacies, Hospitals Pharmacies, and Others)

Publication Month: Apr 2021 | Report Code: TIPRE00003536 | No. of Pages: 162 | Category: Pharmaceuticals | Status: Published

Market Insights

Joint Pain Injection Market to Grow at a CAGR of 8.5% to reach US$ 6,996.88 Mn Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The joint pain injection market is expected to reach US$ 6,996.88 million by 2028 from US$ 3,667.45 million in 2020; it is estimated to grow at a CAGR of 8.5% during 2021–2028.

Joint pain injections provide faster relief from severe pain and reduce inflammation of joints. Several types of injections available in the market include corticosteroids injections, hyaluronic acid (HA) injections, platelet-rich plasma (PRP) injections, and placental tissue matrix (PTM) injections. The growth of the joint pain injection market is attributed to the factors such as high prevalence of musculoskeletal disorders and increasing number of sports injuries. However, high costs of joint repair therapies hinder the market growth

Lucrative Regions for Joint Pain Injection Market
Lucrative Regions for Joint Pain Injection Market

Get more information on this report :




Market Insights


High Prevalence of Musculoskeletal Disorders

Musculoskeletal disorders are medical conditions affecting muscles, bones, and joints of neck, shoulders, wrists, back, hips, legs, knees, and feet. These diseases include tendinitis, carpal tunnel syndrome, osteoarthritis, rheumatoid arthritis (RA), fibromyalgia, and bone fractures. As per the World Health Organization (WHO) factsheet updated in 2018, musculoskeletal conditions are the second-largest contributor to disability worldwide. According to the same, the prevalence and impact of musculoskeletal disorders is expected to rise with the increase in aging population and rise in the prevalence of risk factors of noncommunicable diseases (NCDs) worldwide. As per 2016 American Academy of Orthopedic Surgeons’ annual meeting data, ~1 in 2 adults is suffering from a musculoskeletal disorder in the US. Further, according to the Centers for Disease Control and Prevention (CDC), arthritis causes severe pain that affects millions of people in the US every year. Around one in four arthritis patients, i.e., ~15 million of total ~54 million patients, experiences severe arthritis-related joint pain.

Further, osteoarthritis (OA) is one of the most common joint disorders in the US, caused by the breakdown of joint cartilage between bones. It is also known as degenerative joint disease or “wear and tear” arthritis. As per the Centers for Disease Control and Prevention (CDC), more than 32.5 million adults in the US suffer from osteoarthritis. Similarly, as per the National Health Service (NHS), more than 10 million people in the UK have arthritis or other similar conditions that affect joints. As per the Bupa Health Insurance, osteoarthritis is the most common form of arthritis prevalent in the UK, it affects around the one-third of people aged 45 or more in the country, i.e., ~8.75 million people. Therefore, such high prevalence of musculoskeletal disorders in different countries is increasing the number of treatment procedures being carried out for the same, thereby driving the joint pain injection market growth.

Drugs-Based Insights

The joint pain injection market, by drug, is segmented into hyaluronic acid, corticosteroid, and others. The corticosteroid segment held the largest share of the market in 2020, and it is further anticipated to register the highest CAGR during the forecast period.

Joint pain injection Market, by Drug– 2020 and 2028
Joint pain injection Market, by Drug– 2020 and 2028

Get more information on this report :



Joint Type-based Insights

Based on joint type, the joint pain injection market is segmented into knee, foot and ankle, shoulder and elbow, hips, and other applications. The knee segment held the largest market share in 2020 and is anticipated to register the highest CAGR in the market during the forecast period.

Distribution Channel-based Insights

Based on distribution channel, the joint pain injection market is segmented into retail pharmacies, hospitals pharmacies, and others. The wound care segment held the largest market share in 2020, and the bone grafts segment is estimated to register the highest CAGR in the market during the forecast period.

Strategic Insights

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the joint pain injection market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.

Joint Pain Injection Market – by Drug

  • Hyaluronic Acid
  • Corticosteroid
  • Others

Joint Pain Injection Market – by Joint Type

  • Knee
  • Foot and Ankle
  • Shoulder and Elbow
  • Hip
  • Others

Joint Pain Injection Market – by Distribution Channel

  • Retail Pharmacies
  • Hospitals Pharmacies
  • Others

Joint Pain Injection Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • Chugai Pharmaceutical Co., Ltd.
  • Bioventus Inc.
  • Fidia Pharma USA Inc.
  • Flexion Therapeutics, Inc.
  • SEIKAGAKU CORPORATION
  • Ferring B.V.
  • Sanofi
  • Anika Therapeutics, Inc.
  • Teva Pharmaceutical
  • OrthogenRx, Inc.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Joint Pain Injection Market – By Drug

1.3.2 Global Joint Pain Injection Market – By Joint Type

1.3.3 Global Joint Pain Injection Market – By Distribution Channel

1.3.4 Global Joint Pain Injection Market – By Geography

2. Joint Pain Injection Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global Joint Pain Injection – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East and Africa (MEA) – PEST Analysis

4.2.5 South and Central America (SCAM) – PEST Analysis

4.3 Expert Opinions

5. Joint Pain Injection Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 High Prevalence of Musculoskeletal Disorders

5.1.2 Increasing Number of Sports Injuries

5.2 Market Restraints

5.2.1 High Costs of Joint Repair Therapies

5.3 Market Opportunities

5.3.1 Proliferation of Pharmaceutical Sector in Emerging Markets

5.4 Future Trends

5.4.1 Product Innovations

5.5 Impact Analysis

6. Joint Pain Injection Market – Global Analysis

6.1 Global Joint Pain Injection Market Revenue Forecast And Analysis

6.2 Global Joint Pain Injection Market, By Geography - Forecast And Analysis

6.3 Market Positioning of Key Players

7. Joint Pain Injection Market Analysis – By Drugs

7.1 Overview

7.2 Joint Pain Injection Market Revenue Share, by Drugs (2020 and 2028)

7.3 Hyaluronic Acid

7.3.1 Overview

7.3.2 Hyaluronic Acid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Corticosteroid

7.4.1 Overview

7.4.2 Corticosteroid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Others

7.5.1 Overview

7.5.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

8. Joint Pain Injection Market Analysis – By Joint Type

8.1 Overview

8.2 Joint Pain Injection Market Revenue Share, by Joint Type (2020 and 2028)

8.3 Knee

8.3.1 Overview

8.3.2 Knee: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Hip

8.4.1 Overview

8.4.2 Hip: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Foot and Ankle

8.5.1 Overview

8.5.2 Foot and Ankle: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Shoulder and Elbow

8.6.1 Overview

8.6.2 Shoulder and Elbow: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

9. Joint Pain Injection Market Analysis – By Distribution Channel

9.1 Overview

9.2 Joint Pain Injection Market Share, by Distribution Channel, 2020 and 2028, (%)

9.3 Hospital Pharmacies

9.3.1 Overview

9.3.2 Hospital Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Retail Pharmacies

9.4.1 Overview

9.4.2 Retail Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

10. Joint Pain Injection Market – Geographical Analysis

10.1 North America: Joint Pain Injection Market Revenue and Forecast to 2028

10.1.1 Overview

10.1.2 North America: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.1.3 North America: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.1.4 North America: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.1.5 North America: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.6 North America: Joint Pain Injection Market, by Country, 2020 & 2028 (%)

10.1.7 US: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.1.7.1 US: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.1.7.2 US: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.1.7.3 US: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.1.7.4 US: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.8 Canada: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.1.8.1 Canada: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.1.8.2 Canada: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.1.8.3 Canada: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.1.8.4 Canada: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.1.9 Mexico: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.1.9.1 Mexico: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.1.9.2 Mexico: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.1.9.3 Mexico: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.1.9.4 Mexico: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.2 Europe: Joint Pain Injection Market Revenue and Forecast to 2028

10.2.1 Overview

10.2.2 Europe: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.2.3 Europe: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.2.4 Europe: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.2.5 Europe: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.6 Europe: Joint Pain Injection Market, by Country, 2020 & 2028 (%)

10.2.7 Germany: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.2.7.1 Germany: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.2.7.2 Germany: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.2.7.3 Germany: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.2.7.4 Germany: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.8 UK: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.2.8.1 UK: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.2.8.2 UK: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.2.8.3 UK: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.2.8.4 UK: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.9 France: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.2.9.1 France: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.2.9.2 France: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.2.9.3 France: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.2.9.4 France: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.10 Italy: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.2.10.1 Italy: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.2.10.2 Italy: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.2.10.3 Italy: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.2.10.4 Italy: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.11 Spain: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.2.11.1 Spain: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.2.11.2 Spain: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.2.11.3 Spain: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.2.11.4 Spain: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.2.12 Rest of Europe: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.2.12.1 Rest of Europe: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.2.12.2 Rest of Europe: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.2.12.3 Rest of Europe: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.2.12.4 Rest of Europe: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.3 Asia Pacific: Joint Pain Injection Market Revenue and Forecast to 2028

10.3.1 Overview

10.3.2 Asia Pacific: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.3.3 Asia Pacific: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.3.4 Asia Pacific: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.3.5 Asia Pacific: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.3.6 Asia Pacific: Joint Pain Injection Market, by Country, 2020 & 2028 (%)

10.3.7 China: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.3.7.1 China: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.3.7.2 China: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.3.7.3 China: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.3.7.4 China: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.3.8 Japan: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.3.8.1 Japan: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.3.8.2 Japan: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.3.8.3 Japan: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.3.8.4 Japan: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.3.9 India: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.3.9.1 India: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.3.9.2 India: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.3.9.3 India: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.3.9.4 India: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.3.10 South Korea: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.3.10.1 South Korea: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.3.10.2 South Korea: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.3.10.3 South Korea: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.3.10.4 South Korea: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.3.11 Australia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.3.11.1 Australia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.3.11.2 Australia: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.3.11.3 Australia: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.3.11.4 Australia: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.3.12 Rest of Asia Pacific: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.3.12.1 Rest of Asia Pacific: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.3.12.2 Rest of Asia Pacific: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.3.12.3 Rest of Asia Pacific: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.3.12.4 Rest of Asia Pacific: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.4 Middle East & Africa: Joint Pain Injection Market Revenue and Forecast to 2028

10.4.1 Overview

10.4.2 Middle East and Africa: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.4.3 Middle East and Africa: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.4.4 Middle East and Africa: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.4.5 Middle East and Africa: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.4.6 Middle East and Africa: Joint Pain Injection Market, by Country, 2020 & 2028 (%)

10.4.7 South Africa: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.4.7.1 South Africa: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.4.7.2 South Africa: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.4.7.3 South Africa: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.4.7.4 South Africa: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.4.8 Saudi Arabia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.4.8.1 Saudi Arabia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.4.8.2 Saudi Arabia: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.4.8.3 Saudi Arabia: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.4.8.4 Saudi Arabia: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.4.9 UAE: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.4.9.1 UAE: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.4.9.2 UAE: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.4.9.3 UAE: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.4.9.4 UAE: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.4.10 Rest of Middle East and Africa: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.4.10.1 Rest of Middle East and Africa: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.4.10.2 Rest of Middle East and Africa: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.4.10.3 Rest of Middle East and Africa: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.4.10.4 Rest of Middle East and Africa: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.5 South and Central America: Joint Pain Injection Market Revenue and Forecast to 2028

10.5.1 South and Central America: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.5.2 South and Central America: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.5.3 South and Central America: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.5.4 South and Central America: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.5.5 South and Central America: Joint Pain Injection Market, by Country, 2020 & 2028 (%)

10.5.6 Brazil: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.1 Brazil: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.5.6.2 Brazil: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.5.6.3 Brazil: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.5.6.4 Brazil: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.5.7 Argentina: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.5.7.1 Argentina: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.5.7.2 Argentina: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.5.7.3 Argentina: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.5.7.4 Argentina: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

10.5.8 Rest of South and Central America: Joint Pain Injection Market- Revenue and Forecasts to 2027 (USD Million)

10.5.8.1 Rest of South and Central America: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

10.5.8.2 Rest of South and Central America: Joint Pain Injection Market, by Drugs, 2019–2028 (USD Million)

10.5.8.3 Rest of South and Central America: Joint Pain Injection Market, by Joint Type, 2019–2028 (USD Million)

10.5.8.4 Rest of South and Central America: Joint Pain Injection Market, by Distribution Channel, 2019–2028 (USD Million)

11. Impact of COVID-19 Pandemic on Global Joint Pain Injection Market

11.1 North America: Impact Assessment of COVID-19 Pandemic

11.2 Europe: Impact Assessment of COVID-19 Pandemic

11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Joint Pain Injection Market – Industry Landscape

12.1 Overview

12.2 Growth Strategies Done by the Companies in the Market, (%)

12.3 Organic Developments

12.3.1 Overview

12.4 Inorganic Developments

12.4.1 Overview

13. Appendix

13.1 About the Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 2. Drugs

Table 3. North America Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 4. Joint Type

Table 5. North America Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 6. Distribution Channel

Table 7. US Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 8. Drugs

Table 9. US Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 10. Joint Type

Table 11. US Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 12. Distribution Channel

Table 13. Canada Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 14. Drugs

Table 15. Canada Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 16. Joint Type

Table 17. Canada Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 18. Distribution Channel

Table 19. Mexico Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 20. Drugs

Table 21. Mexico Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 22. Joint Type

Table 23. Mexico Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 24. Distribution Channel

Table 25. Europe Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 26. Drugs

Table 27. Europe Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 28. Joint Type

Table 29. Europe Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 30. Distribution Channel

Table 31. Germany Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 32. Drugs

Table 33. Germany Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 34. Joint Type

Table 35. Germany Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 36. Distribution Channel

Table 37. UK Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 38. Drugs

Table 39. UK Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 40. Joint Type

Table 41. UK Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 42. Distribution Channel

Table 43. France Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 44. Drugs

Table 45. France Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 46. Joint Type

Table 47. France Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 48. Distribution Channel

Table 49. Italy Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 50. Drugs

Table 51. Italy Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 52. Joint Type

Table 53. Italy Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 54. Distribution Channel

Table 55. Spain Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 56. Drugs

Table 57. Spain Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 58. Joint Type

Table 59. Spain Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 60. Distribution Channel

Table 61. Rest of Europe Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 62. Drugs

Table 63. Rest of Europe Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 64. Joint Type

Table 65. Rest of Europe Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 66. Distribution Channel

Table 67. Asia Pacific Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 68. Drugs

Table 69. Asia Pacific Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 70. Joint Type

Table 71. Asia Pacific Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Distribution Channel

Table 72. China Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 73. Drugs

Table 74. China Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 75. Joint Type

Table 76. China Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 77. Distribution Channel

Table 78. Japan Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 79. Drugs

Table 80. Japan Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 81. Joint Type

Table 82. Japan Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 83. Distribution Channel

Table 84. India Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 85. Drugs

Table 86. India Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 87. Joint Type

Table 88. India Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Distribution Channel

Table 89. South Korea Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 90. Drugs

Table 91. South Korea Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 92. Joint Type

Table 93. South Korea Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Distribution Channel

Table 94. Australia Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 95. Drugs

Table 96. Australia Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 97. Joint Type

Table 98. Australia Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 99. Distribution Channel

Table 100. Rest of Asia Pacific Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 101. Drugs

Table 102. Rest of Asia Pacific Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 103. Joint Type

Table 104. Rest of Asia Pacific Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 105. Distribution Channel

Table 106. Middle East and Africa Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 107. Drugs

Table 108. Middle East and Africa Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 109. Joint Type

Table 110. Middle East and Africa Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 111. Distribution Channel

Table 112. South Africa Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 113. Drugs

Table 114. South Africa Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 115. Joint Type

Table 116. South Africa Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 117. Distribution Channel

Table 118. Saudi Arabia Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 119. Drugs

Table 120. Saudi Arabia Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 121. Joint Type

Table 122. Saudi Arabia Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 123. Distribution Channel

Table 124. UAE Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 125. Drugs

Table 126. UAE Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Joint Type

Table 127. UAE Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 128. Distribution Channel

Table 129. Rest of Middle East and Africa Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 130. Drugs

Table 131. Rest of Middle East and Africa Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 132. Joint Type

Table 133. Rest of Middle East and Africa Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 134. Distribution Channel

Table 135. South and Central America Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Drugs

Table 136. South and Central America Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Joint Type

Table 137. South and Central America Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Distribution Channel

Table 138. Brazil Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 139. Drugs

Table 140. Brazil Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 141. Joint Type

Table 142. Brazil Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 143. Distribution Channel

Table 144. Argentina Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Drugs

Table 145. Argentina Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Joint Type

Table 146. Argentina Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Distribution Channel

Table 147. Rest of South and Central America Joint Pain Injection Market, by Drugs – Revenue and Forecast to 2028 (USD Million)

Table 148. Drugs

Table 149. Rest of South and Central America Joint Pain Injection Market, by Joint Type – Revenue and Forecast to 2028 (USD Million)

Table 150. Joint Type

Table 151. Rest of South and Central America Joint Pain Injection Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 152. Distribution Channel

Table 153. Organic Developments Done By Companies

Table 154. Inorganic Developments Done By Companies

Table 155. Glossary of Terms, Joint Pain Injection Market

LIST OF FIGURES

Figure 1. Joint Pain Injection Market Segmentation

Figure 2. Joint Pain Injection Market Segmentation, By Region

Figure 3. Joint Pain Injection Market Overview

Figure 4. Knee Joint Type Segment Held Largest Share of Joint Pain Injection Market

Figure 5. North America to Show Significant Growth During Forecast Period

Figure 6. Joint Pain Injection Market, by Geography (US$ Million)

Figure 7. Global Joint Pain Injection Market – Leading Country Markets (US$ Million)

Figure 8. Global Joint Pain Injection Market, Industry Landscape

Figure 9. North America PEST Analysis

Figure 10. Europe PEST Analysis

Figure 11. Asia Pacific PEST Analysis

Figure 12. Middle East and Africa (MEA) PEST Analysis

Figure 13. South and Central America (SCAM) PEST Analysis

Figure 1. Number of Sports Injuries in US, 2019

Figure 2. Joint Pain Injection Market Impact Analysis of Driver and Restraints

Figure 3. Global Joint Pain Injection Market – Revenue Forecast And Analysis – 2020- 2028

Figure 4. Global Joint Pain Injection Market – By Geography Forecast and Analysis – 2019- 2027

Figure 5. Market Positioning Of Key Players In Global Joint Pain Injection Market

Figure 6. Joint Pain Injection Market Revenue Share, by Drugs (2020 and 2028)

Figure 7. Hyaluronic Acid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

Figure 8. Corticosteroid: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

Figure 9. Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Joint Pain Injection Market Revenue Share, by Joint Type (2020 and 2028)

Figure 11. Knee: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Hip: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Foot and Ankle: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Shoulder and Elbow: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Other: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16. Joint Pain Injection Market Share, by Distribution Channel, 2020 and 2028 (%)

Figure 17. Hospital Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Retail Pharmacies: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Others: Joint Pain Injection Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. North America: Joint Pain Injection Market, by Key Country – Revenue (2020) (USD Million)

Figure 21. North America Joint Pain Injection Market Revenue and Forecast to 2028 (USD Million)

Figure 22. North America: Joint Pain Injection Market, by Country, 2020 & 2028 (%)

Figure 23. US: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 24. Canada: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 25. Mexico: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 26. Europe: Joint Pain Injection Market, by Key Country – Revenue (2020) (USD Million)

Figure 27. Europe Joint Pain Injection Market Revenue and Forecast to 2028 (USD Million)

Figure 28. Europe: Joint Pain Injection Market, by Country, 2020 & 2028 (%)

Figure 29. Germany: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. UK: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. France: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Italy: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. Spain: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 34. Rest of Europe: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 35. Asia Pacific: Joint Pain Injection Market, by Key Country – Revenue (2020) (USD Million)

Figure 36. Asia Pacific Joint Pain Injection Market Revenue and Forecast to 2028 (USD Million)

Figure 37. Asia Pacific: Joint Pain Injection Market, by Country, 2020 & 2028 (%)

Figure 38. China: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 39. Japan: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 40. India: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 41. South Korea: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 42. Australia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 43. Rest of Asia Pacific: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 44. Middle East and Africa: Joint Pain Injection Market, by Key Country – Revenue (2020) (USD Million)

Figure 45. Middle East and Africa Joint Pain Injection Market Revenue and Forecast to 2028 (USD Million)

Figure 46. Middle East and Africa: Joint Pain Injection Market, by Country, 2020 & 2028 (%)

Figure 47. South Africa: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 48. Saudi Arabia: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 49. UAE: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 50. Rest of Middle East and Africa: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 51. South and Central America: Joint Pain Injection Market, by Key Country – Revenue (2020) (USD Million)

Figure 52. South and Central America Joint Pain Injection Market Revenue and Forecast to 2028 (USD Million)

Figure 53. South and Central America: Joint Pain Injection Market, by Country, 2020 & 2028 (%)

Figure 54. Brazil: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 55. Argentina: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 56. Rest of South and Central America: Joint Pain Injection Market – Revenue and Forecast to 2028 (USD Million)

Figure 57. Impact of COVID-19 Pandemic in North American Country Markets

Figure 58. Impact of COVID-19 Pandemic in Europe Country Markets

Figure 59. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

Figure 60. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 61. Impact of COVID-19 Pandemic in Rest of World Country Markets

Figure 62. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - Joint Pain Injection Market

  1. Chugai Pharmaceutical Co., Ltd.              
  2. Bioventus Inc.                
  3. Fidia Pharma USA Inc.                
  4. Flexion Therapeutics, Inc.          
  5. SEIKAGAKU CORPORATION       
  6. Ferring B.V.     
  7. Sanofi              
  8. Anika Therapeutics, Inc.             
  9. Teva Pharmaceutical                  
  10. OrthogenRx, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the joint pain injection market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global joint pain injection market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00003536
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Joint pain injections are medicinal fluids inserted in the patient’s body to get faster relief from severe pain. The joint pain injections are used to reduce inflammation in the joints. There are several types of injections available in the market which are corticosteroids injections, hyaluronic acid (HA) injections, platelet-rich plasma (PRP) injections and placental tissue matrix (PTM) injections.

The global joint pain injection market growth is mainly attributed to factors such the high prevalence of musculoskeletal disorders and increasing number of sports injuries. However, the high costs of joint repair therapies hinder the market growth.

The joint pain injection market majorly consists of the players such as Chugai Pharmaceutical Co., Ltd., Teva Pharmaceuticals, Bioventus Inc., Fidia Pharma USA Inc., Flexion Therapeutics, Inc., SEIKAGAKU CORPORATION, Ferring B.V., Sanofi, Anika Therapeutics, Inc., and OrthogenRx among others.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.